Effect of cultivar and formaldehyde treatment of barley grain on rumen fermentation characteristics using in vitro gas production

The aim of this study was to determine the effects of cultivar and formaldehyde treatment of barley grains on rumen fermentation characteristics using the in vitro gas production technique. Amount of gas produced (mL/g organic matter (OM)) during fermentation was determined after 0, 3, 6, 12, 24, 48, 72 and 96 h of incubation in buffered rumen fluid. The gas production kinetics were described using the equation: y = A {1 – exp [- b (t-T) – c (√t - √T)]} where b and c are the initial gas production rate constant (h-1) and later gas production rate constant (h-1/2), respectively. Cultivar and formaldehyde treatment had significant effects on gas production kinetics. Total gas production (A) ranged from 389.9 to 410.8 (mL/g OM) with the cultivar, Esterel, producing the largest volume of gas of the cultivars. Due to low gas production rates at 3, 6 and 12 h of incubation the cultivars, Viva and Cecilla, took the longest to produce 50% of their total volume of gas. Formaldehyde treatment reduced the rate (μ) of gas production at 3, 6 and 12 h of incubation, and the total volume of gas (A), but increased the time (h) to produce 50% of A and reduced the time (h) to produce 95% of A. The reduction in gas production ranged from 33.3 to 51 mL/g OM with 6 h incubation showing the highest decrease in gas production. It is concluded that formaldehyde treatment may provide an opportunity to manipulate the site of digestion of barley grain in the digestive tract of ruminants. Through the selection of suitable cultivars and through formaldehyde treatment the nutritional and health problems associated with the fermentation of barley grain in the rumen could be reduced. Keywords: Barley cultivars; formaldehyde treatment; gas production kinetics South African Journal of Animal Sciences Vol. 35 (3) 2005: pp.206-21

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Interindividual clinical variability in the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is vast. We report that at least 101 of 987 patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia had neutralizing immunoglobulin G (IgG) autoantibodies (auto-Abs) against interferon-w (IFN-w) (13 patients), against the 13 types of IFN-a (36), or against both (52) at the onset of critical disease; a few also had auto-Abs against the other three type I IFNs. The auto-Abs neutralize the ability of the corresponding type I IFNs to block SARS-CoV-2 infection in vitro. These auto-Abs were not found in 663 individuals with asymptomatic or mild SARS-CoV-2 infection and were present in only 4 of 1227 healthy individuals. Patients with auto-Abs were aged 25 to 87 years and 95 of the 101 were men. A B cell autoimmune phenocopy of inborn errors of type I IFN immunity accounts for life-threatening COVID-19 pneumonia in at least 2.6% of women and 12.5% of men

Novel non-synonymous polymorphisms in the COX-1 gene in Turkish pediatric patients with cardiovascular anomalies

Variation in the gene encoding cyclooxygenase-1 (COX-1) is involved in the process of aspirin resistance. This study investigated the genetic variations in the COX-1 gene. The 4 coding regions of the human COX-1 gene in 90 pediatric patients (median age of 6.5 months, 55% males) with cardiovascular anomalies were screened using DNA sequencing. Twenty coding-region variants causing amino acid substitutions as well as 2 new non-synonymous polymorphisms were identified. All variants were compared with an independent Caucasian population (N = 24 unrelated individuals). Most of the discovered polymorphisms were rare, although some variants resulted in amino acid changes occurring at a frequency >5% (W8R, P17L, Q41Q, Q240Q, D189E, and P188P). In addition, 2 new non-synonymous polymorphisms (F200L and D189E) were identified. These findings demonstrated novel genetic variants of the human COX-1 gene. Future studies characterizing the functional impact of these variants are warranted